Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN
May 12, 2021
Japan prepares to inoculate adolescents under 16 against COVID-19
A health ministry official said the benefit of inoculating those between 12 and 15 will be significant amid the spread of highly transmissible coronavirus variants in the country.
Japan Times
ASIA PACIFIC
May 12, 2021
China’s Sinovac shot found highly effective in real world study
Indonesian data adds to signs out of Brazil that the shot is more effective than it proved in the testing phase, which was beset by divergent efficacy rates and questions over transparency.
Japan Times
WORLD
May 11, 2021
Pfizer-BioNTech COVID-19 shot cleared for adolescents in U.S.
The move comes ahead of the summer camp season and before the start of the new school year in September.
Japan Times
ASIA PACIFIC
May 8, 2021
WHO approves Sinopharm vaccine in potential boost to COVAX pipeline
The vaccine, one of two main Chinese coronavirus vaccines, is the first developed by a non-Western country to win WHO backing.
Japan Times
EDITORIALS
May 8, 2021
World shares India’s pain with growing COVID-19 crisis
The WHO estimates that 25% of global deaths last week occurred in India, a death toll that exceeded 3,700 lives per day.
Japan Times
JAPAN
May 8, 2021
Japan pharma industry opposes U.S. backing for vaccine patent waiver
The Japan Pharmaceutical Manufacturers Association said it is concerned that noneffective products may circulate, and the risk of side effects could increase as well.
Japan Times
ASIA PACIFIC
May 7, 2021
The world turns to China for vaccines after India and U.S. stumble
Some experts are worried about the potential impact of widely deploying Chinese shots that have demonstrated lower efficacy rates than those made by Pfizer and Moderna.
Japan Times
WORLD
May 7, 2021
Biden's vaccine-patent gambit turns up the heat on drugmakers
By supporting the World Trade Organization process, the U.S. president can satisfy progressives while engaging in talks on a waiver that may never reach consensus.
Japan Times
WORLD
May 6, 2021
In a reversal, U.S. backs giving poorer countries access to COVID-19 vaccine patents and tech
'This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,' Biden's top trade negotiator said in a statement
Japan Times
WORLD
May 4, 2021
White House backs Pfizer’s move to begin vaccine exports
Early U.S. production wasn't subject to an export ban but was gobbled up entirely by the government, which used wartime powers to prioritize its orders.
Japan Times
WORLD / Science & Health
May 1, 2021
Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds
A single dose of the vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19.
Japan Times
JAPAN
May 1, 2021
Japan to approve Moderna vaccine as soon as May 21, report says
The Moderna vaccine would be the second to get approved in Japan and will be used in the nation's large inoculation centers that will open in Tokyo and Osaka from May 24, the report said.
Japan Times
JAPAN
Apr 30, 2021
First batch of Moderna COVID-19 vaccine arrives in Japan
It will become the second type of shot available in the country after the one developed by Pfizer Inc. if a health ministry panel greenlights it as early as May 20.
Japan Times
JAPAN / Science & Health
Apr 30, 2021
With large vaccine studies harder to carry out, regulators look for alternatives
The start of inoculation campaigns has made it difficult for some nations to recruit a sufficient number of test subjects who have no immunity against the coronavirus.
Japan Times
WORLD / Science & Health
Apr 30, 2021
COVID-19 shots come in bulk, but the world needs single servings
Vials full of doses often must be kept in extreme cold, and once opened have to be used quickly, making delivery to smaller, far-flung populations difficult.
Japan Times
WORLD / Science & Health
Apr 29, 2021
Dark horse of vaccine race may be this French biotech
With the other COVID-19 vaccines in Europe focused on the virus's spike protein, this shot could protect against variants that might compromise others, making it the perfect booster.
Japan Times
WORLD
Apr 26, 2021
When it comes to a restart of global travel, all vaccines are not equal
A patchwork of approvals across the world is laying the groundwork for a global vaccine bifurcation, where the shot you get could determine which countries you can enter and work in.
Japan Times
WORLD
Apr 24, 2021
U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately
Officials found just 15 cases among the 8 million shots given that had experienced the syndrome involving severe blood clots and low platelets as a result of the vaccine.
Japan Times
ASIA PACIFIC
Apr 23, 2021
How South Korea stepped up specialty syringe production for COVID-19 vaccines
South Korea's relative abundance of low dead space syringes has helped it give 3.4% of its population at least one dose of a coronavirus vaccine, compared with 1.1% in Japan.
Japan Times
WORLD
Apr 22, 2021
U.S. weighs global vaccine intellectual property waiver opposed by drugmakers
The European Union, U.K., Japan, Switzerland, Brazil and Norway are also among territories resisting the measure currently before the WTO.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'